Cargando…

The reorganization in the post-COVID recovery period requires a rationalization of old schedules of surveillance of non-muscle invasive bladder cancer

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694463/ http://dx.doi.org/10.1016/j.urolonc.2020.10.003

Ejemplares similares

Cost‐effectiveness of surveillance schedules in older adults with non‐muscle‐invasive bladder cancer
por: Heijnsdijk, Eveline A.M., et al.
Publicado: (2018)

Active surveillance for non-muscle invasive bladder cancer
por: Marcq, Gautier, et al.
Publicado: (2019)

Surveillance and Treatment of Non-Muscle-Invasive Bladder Cancer in the USA
por: Barocas, Daniel A., et al.
Publicado: (2012)

Reorganization of nurse scheduling reduces the risk of healthcare associated infections
por: Valdano, Eugenio, et al.
Publicado: (2021)

Optimal schedule of bacillus calmette-guerin for non-muscle-invasive bladder cancer: a meta-analysis of comparative studies
por: Zhu, Shimiao, et al.
Publicado: (2013)

MRI-Linac Economics II: Rationalizing Schedules
por: Johnstone, Peter A. S., et al.
Publicado: (2022)

An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer
por: Soria, Francesco, et al.
Publicado: (2018)

Surveillance of Low-Grade Non-Muscle Invasive Bladder Tumors Using Uromonitor: SOLUSION Trial
por: Azawi, Nessn, et al.
Publicado: (2023)

Comparing CxBladder to Urine Cytology as Adjunct to Cystoscopy in Surveillance of Non-muscle Invasive Bladder Cancer—A Pilot Study
por: Chai, C. A., et al.
Publicado: (2021)

Functional connectome reorganization relates to post-stroke motor recovery and structural and functional disconnection
por: Olafson, Emily R., et al.
Publicado: (2021)

Utilising alternative cystoscopic schedules to minimise cost and patient burden after trimodality therapy for muscle‐invasive bladder cancer
por: Krishnatry, Rahul, et al.
Publicado: (2023)

Reversible differentiation of immortalized human bladder smooth muscle cells accompanied by actin bundle reorganization
por: Hashimoto, Naohiro, et al.
Publicado: (2017)

Predictors of Outcome of Non–Muscle-Invasive and Muscle-Invasive Bladder Cancer
por: Youssef, Ramy F., et al.
Publicado: (2011)

Quality of life in patients undergoing surveillance for non-muscle invasive bladder cancer—a systematic review
por: Nayak, Arvind, et al.
Publicado: (2021)

Treatment and surveillance for non-muscle-invasive bladder cancer: a clinical practice guideline (2021 edition)
por: Jin, Ying-Hui, et al.
Publicado: (2022)

Is Regular Radiographic Upper Urinary Tract Imaging for Surveillance of Non-Muscle Invasive Bladder Cancer Justified?
por: Bieri, Uwe, et al.
Publicado: (2022)

Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer
por: Zhu, Huier, et al.
Publicado: (2019)

What Is the Nature of Poststroke Language Recovery and Reorganization?
por: Kiran, Swathi
Publicado: (2012)

Bladder Preservation for Muscle Invasive Bladder Cancer
por: Mirza, Arafat, et al.
Publicado: (2016)

Understanding risk and refining surveillance following tumor resection for low grade non-muscle invasive bladder cancer
por: Peyton, Charles C., et al.
Publicado: (2018)

Current status of genetic urinary biomarkers for surveillance of non-muscle invasive bladder cancer: a systematic review
por: Lozano, F., et al.
Publicado: (2020)

Active surveillance for nonmuscle invasive bladder cancer
por: Miyake, Makito, et al.
Publicado: (2016)

Tonotopic reorganization and spontaneous firing in inferior colliculus during both short and long recovery periods after noise overexposure
por: Wang, Feng, et al.
Publicado: (2013)

Post-transcriptional regulation of MRE11 expression in muscle-invasive bladder tumours
por: Martin, Rebecca M., et al.
Publicado: (2014)

Stepwise Application of Urine Markers to Detect Tumor Recurrence in Patients Undergoing Surveillance for Non-Muscle-Invasive Bladder Cancer
por: Todenhöfer, Tilman, et al.
Publicado: (2014)

Clinical Validation of a Urine Test (Uromonitor-V2(®)) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients
por: Sieverink, Caroline A., et al.
Publicado: (2020)

The Role of Fluorescence In Situ Hybridization in the Surveillance of Non-Muscle Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis
por: Zheng, Weitao, et al.
Publicado: (2022)

Bladder Sparing Approaches for Muscle-Invasive Bladder Cancers
por: El-Taji, Omar M. S., et al.
Publicado: (2016)

New psychoactive substances in Taiwan: The current situation and initiative for rational scheduling
por: Yu, Wen-Jing, et al.
Publicado: (2021)

Tinnitus does not require macroscopic tonotopic map reorganization
por: Langers, Dave R. M., et al.
Publicado: (2012)

Outcomes of bacillus Calmette–Guérin therapy without a maintenance schedule for high‐risk non‐muscle‐invasive bladder cancer in the second transurethral resection era
por: Kikuchi, Hiroshi, et al.
Publicado: (2021)

Non-muscle invasive bladder cancer risk stratification
por: Isharwal, Sumit, et al.
Publicado: (2015)

Intravesical chemotherapy in non-muscle-invasive bladder cancer
por: Porten, Sima P., et al.
Publicado: (2015)

Molecular Landscape of Non-Muscle Invasive Bladder Cancer
por: Messing, Edward M.
Publicado: (2018)

Prediction tools in non-muscle invasive bladder cancer
por: Zamboni, Stefania, et al.
Publicado: (2019)

Histological variants in non-muscle invasive bladder cancer
por: Baumeister, Philipp, et al.
Publicado: (2019)

The present and future of non-muscle invasive bladder cancer
por: Moschini, Marco, et al.
Publicado: (2019)

Renal Granulomatosis Post Intravesical Bacillus Calmette–Guerin Therapy for Non-muscle-invasive Bladder Cancer
por: Tran-Harding, Karen, et al.
Publicado: (2018)

Non-muscle invasive urothelial bladder cancer in a 17-year-old male: A rare case report
por: Hmaidy, Osama, et al.
Publicado: (2023)

Impact of an optimized surveillance protocol based on the European Association of Urology substratification on surveillance costs in patients with primary high-risk non-muscle-invasive bladder cancer
por: Fujita, Naoki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4hdlu0mbd9v3dt31m0vgcga80n